BCL-2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy

Journal of Cellular Biochemistry

Volumn 60, Issue 1, 1996, Pages 23-32

  Reed, John C ^a   Miyashita, Toshiyuki ^a   Takayama, Shinichi ^a   Wang, Hong Gang ^a   Sato, Takaaki ^a   Krajewski, Stanislaw ^a   Aimésempé, Christine ^a   Bodrug, Sharon ^a   Kitada, Shinichi ^a   Hanada, Motoi ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

BCL 2 gene; Bcl 2 protein; cancer; homo and heterotypic dimers; homologs

Indexed keywords

ANTINEOPLASTIC AGENT; ONCOPROTEIN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; GENE EXPRESSION REGULATION; GENE LOCATION; GROWTH REGULATION; HUMAN; HUMAN CELL; LYMPHOMA; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; PROTO ONCOGENE; REGULATOR GENE; TREATMENT FAILURE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

APOPTOSIS; DRUG RESISTANCE, NEOPLASM; GENES, REGULATOR; HUMANS; NEOPLASMS; ONCOGENES; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 9044225527     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19960101)60:1<23::AID-JCB5>3.0.CO;2-5     Document Type: Article

References (55)

1. Baffy G, Miyashita T, Williamson JR, Reed JC (1993) : Apoptosis induced by withdrawal of Interleukin-3 [IL-3] from an IL-3-dependent hematopoietic cell line associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J Biol Chem 268:6511-6519.
2. Bodrug SE, Aimé-Sempé C, Sato T, Krajewski S, Hanada M, Reed JC (1995): Biochemical and functional comparisons of Mcl-1 and Bcl-2 proteins: Evidence for a novel mechanism of regulating Bcl-2 family protein function. Cell Death Diff 2:173-182.
3. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB (1993): bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608.
4. Borner C, Martinou I, Mattmann C, Irmler M, Scharer E, Martinou J-C, Tschopp J (1994): The protein bcl-2alpha does not require membrane attachment, but two conserved domains to suppress apoptosis. J Cell Biol 126:1059-1068.
5. Boyd JM, Malstrom S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B, D'Sa-Eipper C, Chinnadurai G (1994): Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 79:341-351.
6. Cazals-Hatem D, Louie D, Tanaka S, Reed JC (1992): Molecular cloning and DNA sequence analysis of cDNA encoding chicken homolog of the bcl-2 oncoprotein. Biochim Biophys Acta 1132:109-113.
7. Chiou S-K, Tseng C-C, Rao L, White E (1994): Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J Virol 68:6553-6566.
8. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC (1995): Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374:733-736.
9. de Jong D, Prins FA, Mason DY, Reed JC, van Ommen GB, Kluin PM (1994): Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells. Cancer Res 54:256-260.
10. Dowd DR, MacDonald PN, Komm BS, Haussler MR, Miesfeld RL (1992): Stable expression of the calbindin-D28K complementary DNA interferes with the apoptotic pathway in lymphocytes. Mol Endocrinol 6:1843-1848.
11. Farrow SN, White JHM, Martinou I, Raven T, Pun K-T, Grinham CJ, Martinou J-C, Brown R (1995): Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 374:731-733.
12. Fernandez-Sarbia MJ, Bischoff JR (1993): Bcl-2 associates with the ras-related protein R-ras p23. Nature 366:274-275.
13. Haldar S, Jena N, Croce CM (1995): Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92:4507-4511.
14. Hanada M, Krajewski S, Tanaka S, Cazals-Hatem D, Spengler BA, Ross RA, Biedler JL, Reed JC (1993): Regulation of bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Cancer Res 53:4978-4986.
15. Hanada M, Aimé-Sempé C, Sato T, Reed JC (1995): Structure-function analysis of bcl-2 protein: Identification of conserved domains important for homodimerization with bcl-2 and heterodimerization with box. J Biol Chem 270:11962-11968.
16. Hockenbery D, Oltvai Z, Yin X-M, Milliman C, Korsmeyer SJ (1993): Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251.
17. Jacobson MD, Burne JF, Raff MC (1994): Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 13:1899-1910.
18. Kane DJ, Sarafin TA, Auton S, Hahn H, Gralla FB, Valentine JC, Ord T, Bredesen DE (1993): Bcl-2 inhibition of neural cell death: Decreased generation of reactive oxygen species. Science 262:1274-1276.
19. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Ubansky SR, Tomei LD, Barr PJ (1995): Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374:736-739.
20. Kitada S, Takayama S, DeRiel K, Tanaka S, Reed JC (1994): Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression. Antisense Res Dev 4:71-79.
21. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig R (1993): McI-1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to bcl-2. Proc Natl Acad Sci USA 90:3516-3520.
22. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC (1993): Investigations of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53:4701-4714.
23. Krajewski S, Blomvqvist C, Franssila K, Krajewska M, Wasenius V-M, Niskanen E, Reed JC (1995): Reduced expression of pro-apoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 55:4471-4478.
24. 2- fluxes. Proc Natl Acad Sci USA 91:6569-6573.
25. Lin EY, Orlofsky A, Berger MS, Prystowsky MB (1993): Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J Immunol 151:1979-1988.
26. Magnelli L, Cinelli M, Turchetti A, Chiarugi VP (1994): Bcl-2 overexpression abolishes early calcium waving preceding apoptosis in NIH-3T3 murine fibroblasts. Biochem Biophys Res Commun 204:84-90.
27. Meikrantz W, Gisselbrecht S, Tam SW, Schlegel R (1994): Activation of cyclin A-dependent protein kinases during apoptosis. Proc Natl Acad Sci USA 91:3754-3758.
28. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J (1994): Induction of apoptosis in fibroblasts by IL-1 b-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75:653-660.
29. Miyashita T, Reed JC (1992): Bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucoeorticoids and multiple chemotherapeutic drugs. Cancer Res 52:5407-5411.
30. Miyashita T, Reed JC (1993): Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151-157.
31. Miyashita T, Reed JC (1995): Tumor suppressor p53 is a direct transcriptional activator of human bax gene. Cell 80:293-299.
32. Miyashita T, Krajewski S, Krajewski M, Wang HG, Lin HK, Hoffman B, Lieberman D, Reed JC (1994a): Tumor suppressor p53 is a regulator of bcl-2 and box in gene expression in vitro and in vivo. Oncogene 9:1799-1805.
33. Miyashita T, Harigai M, Hanada M, Reed JC (1994b): Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54:3131-3135.
34. Newmeyer D, Farschon DM, Reed JC (1994): Cell-free apoptosis in Xenopus egg extracts: By Bcl-2 inhibits a latant cytoplasmic phase. Cell 79:353-364.
35. Oltvai Z, Milliman C, Korsmeyer SJ (1993): Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619.
36. Perego P, Giarola M, Pierotti M, Miyashita T, Reed JC, Righetti S, Zunino F (1996): Association between cisplatin resistance and mutation of p53 and reduced Bax expression in ovarian carcinoma cell systems. Cancer Res, in press.
37. Reed JC (1994,): Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1-6.
38. Reed JC (1995): Bcl-2: Prevention of apoptosis as a mechanism of drug resistance Hematol Oncol Clin North Am 9:451-473.
39. Ryan JJ, Prochownik E, Gottlieb CA, Apel IJ, Merino R, Nuñez G, Clarke MF (1994): c-myc and bcl-2 modulates p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci USA 91:5878-5882.
40. Sato T, Hanada M, Bodrug S, Irie S, Iwama N, Boise LH, Thompson CB, Golemis E, Fong L, Wang H-G, Reed JC (1994): Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 91:9238-9242.
41. Sato T, Hanada M, Bodrug S, Irie S, Iwama N, Boise LH, Thompson CB, Golemis E, Fong L, Wang H-G, Reed JC (1995): Correction: Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 92:1793.
42. Selvakumaran M, Lin H-K, Miyashita T, Wang H-G, Krajewski S, Reed JC, Hoffman B, Liebermann D (1994): Immediate early up-regulation of bax expression by p53 but not TGFb1: A paradigm for distinct apoptotic pathways. Oncogene 9:1791-1798.
43. Silvestrini R, Veneroni S, Daidonem, Benini E, Boracchi P, Mezzetti M, Di Fronzo G (1994): The bcl-2 protein: a prognostic indicator strongly related to p53 in lymph-node negative breast cancer patients. J Natl Cancer Inst 86:499-504.
44. Takayama S, Cazals-Hatem DL, Kitada S, Tanaka S, Miyashita T, Hovey LR, Huen D, Rickinson A, Veerapandian P, Krajewski S, Saito K, Reed JC (1994): Evolutionary conservation of function among mammalian, avian, and viral homologs of the bcl-2 oncoprotein: Structure-function implications. DNA Cell Biol 13:679-692.
45. Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan J, Reed JC (1995): Cloning and functional analysis of BAG-1: A novel Bcl-2 binding protein with anti-cell death activity. Cell 80:279-284.
46. Tanaka S, Saito K, Reed JC (1993): Structure-function analysis of the apoptosis-suppressing bcl-2 oncoprotein: Substitution of a heterologous transmembrane domain restores function to truncated Bcl-2 proteins J Biol Chem 268:10920-10926.
47. Tsujimoto Y, Croce CM (1986): Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83:5214-5218.
48. Tsujimoto Y, Louie E, Bashir MM, Croce CM (1988): The reciprocal partners of both the t(14;18) and t(11;14) translocations involved in B-cell neoplasms are rearranged by the same mechanism. Oncogene 2:347-351.
49. Vaux DL, Cory S, Adams JM (1988): Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442.
50. Wang H-G, Miyashita T, Takayama S, Sato T, Torigoe T, Krajewski S, Tanaka S, Hovey L III, Troppmair J, Rapp UR, Reed JC (1994): Apoptosis regulation by interaction of bcl-2 protein and Raf-1 kinase. Oncogene 9:2751-2756.
51. Wang H-G, Millan JA, Cox AD, Der CJ, Rapp UR, Beck T, Zha H, Reed JC (1995): R-ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism. J Cell Biol 129:1103-1114.
52. L and Bcl-2, displaces box and promotes cell death. Cell 80-285-291.
53. Yin XM, Oltvai ZN, Korsmeyer SJ (1994): BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with box. Nature 369:321-333.
54. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR (1993): The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75:641-652.
55. Zhan Q, Fan S, Bae I, Guillouf C, Liebermann DA, O'Connor PM, Fornace AJ Jr (1994): Induction of box by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 9:3743-3751.